By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > No Safe Smoking Threshold: 50–60% Risk Increase Found at Light Consumption Levels

No Safe Smoking Threshold: 50–60% Risk Increase Found at Light Consumption Levels

GMJ
Last updated: 13/08/2026 03:30
By
Prof. Giorgi Pkhakadze
Share
1 Min Read
Chart showing cardiovascular risk elevation from light smoking and recovery timeline after cessation
A pooled analysis of 302,522 adults in PLOS Medicine found that smoking just 2–5 cigarettes daily elevates heart failure risk by 50% and all-cause mortality by 60%. Former smokers retain elevated cardiovascular risk for 20–30 years after quitting. — Photo by Fabiana Zambrano on Pexels (Pexels License)
SHARE
1 min read|120 words

A landmark pooled analysis of 302,522 adults across 22 longitudinal cohort studies has quantified a sobering reality: smoking as few as 2 to 5 cigarettes per day elevates heart failure risk by 50% and all-cause mortality by 60% compared to never-smokers. This analysis, published in PLOS Medicine and spanning up to 30 years of follow-up data with over 125,000 documented deaths, reveals that the cardiovascular risk curve is nonlinear—the steepest increase occurs between zero and five cigarettes daily.

The dose-response relationship demonstrates conclusively that there is no safe threshold for smoking. Even light smoking carries substantial health consequences. These findings challenge the notion that “cutting back” offers meaningful cardiovascular protection, highlighting the distinction between harm reduction and actual risk mitigation.

Read the full article on GMJ Newsroom.

Was this article helpful?

GMJ Brief · Key Finding

📰 Read the full article: Even Light Smoking Raises Heart Disease Risk by 50–60%, Study Shows—and Quitting Doesn’t Fully Reverse It →

Related reference
  • Heart Failure · Condition
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
What makes prostate cancer aggressive? Biology, genetics, and clinical grading explained

Prostate cancer aggressiveness is determined by histological grade (Gleason score), genetic mutations…

UK childhood vaccination coverage holds steady at high levels, latest quarterly data shows

The UK's Cover of Vaccination Evaluated Rapidly (COVER) programme reports sustained high…

EMA Launches Email Notifications for Clinical Trial Information System

The European Medicines Agency has rolled out email notification subscriptions in CTIS,…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Bar chart comparing muscle protein synthesis across vegan, omnivorous, and meal timing strategies

Announcement: Protein Source and Meal Timing May Matter Less for Muscle Growth Than Assumed

By
Prof. Giorgi Pkhakadze
05/08/2026
Medical illustration showing CAR-T cells targeting lupus-causing B cells in the immune system

Perfect Clinical Outcome: 15 of 15 Lupus Patients Achieve Drug-Free Remission with CAR-T Therapy

By
Prof. Giorgi Pkhakadze
17/07/2026

🚨 WOAH Statement on the Ebola Virus Disease Outbreak in the Democratic Republic of the Congo and Uganda

By
Prof. Giorgi Pkhakadze
20/06/2026
Illustration of brain regions targeted by GLP-1 receptor agonists involved in impulse control and emotional regulation

GLP-1 Use Associated with Substantial Reduction in Impulsivity-Violence Link

By
Prof. Giorgi Pkhakadze
25/07/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up